|
Excipient GMP (Significant new requirements & Implementation of NSF/IPEC/ANSI 363)
|
|
|
|
|
|
Significant Change
|
|
|
|
|
|
3rd Party Excipient Audit
|
|
|
|
|
|
Technically Unavoidable Particles (TUPPs) Guide
|
|
|
|
|
|
Total Excipient Control (TEC)
|
|
|
|
|
|
Elemental Impurities/USP <232> / ICH Q3D
|
|
|
|
|
|
Certificate of Analysis
|
|
|
|
|
|
Validation
|
|
|
|
|
|
Stability
|
|
|
|
|
|
Handling a FDA Inspection
|
|
|
|
|
|
Quality Agreement
|
|
|
|
|
|
Atypical Actives
|
|
|
|
|
|
Excipient Good Distribution Practices
|
|
|
|
|
|
Risk Management/Documenting Risk Assessment
|
|
|
|
|
|
Excipient Composition
|
|
|
|
|
|
Supplier Qualification (from Excipient User Perspective)
|
|
|
|
|